Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer.
Saved in:
| Title: | Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancer. |
|---|---|
| Authors: | Chen DD; Fred Hutchinson Cancer Center, Seattle, WA, USA.; University of Washington, Seattle, WA, USA., Zimmer A; Fred Hutchinson Cancer Center, Seattle, WA, USA., Yang DD; Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Patton R; Fred Hutchinson Cancer Center, Seattle, WA, USA.; University of Washington, Seattle, WA, USA., Crowdis J; Yale School of Medicine, New Haven, CT, USA., Chandra P; Fred Hutchinson Cancer Center, Seattle, WA, USA., Bin Riaz I; Mayo Clinic, Phoenix, AZ, USA., Hanratty B; Fred Hutchinson Cancer Center, Seattle, WA, USA., Rickles-Young M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Tsuji J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cibulskis C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Fleharty M; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Whelpley B; Boston University, Boston, MA, USA., Reardon B; Dana-Farber Cancer Institute, Boston, MA, USA., Park J; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Nelson PS; Fred Hutchinson Cancer Center, Seattle, WA, USA.; University of Washington, Seattle, WA, USA., Huang FW; University of California, San Francisco, San Francisco, CA, USA., Van Allen EM; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ha G; Fred Hutchinson Cancer Center, Seattle, WA, USA. gha@fredhutch.org.; University of Washington, Seattle, WA, USA. gha@fredhutch.org., Choudhury AD; Dana-Farber Cancer Institute, Boston, MA, USA. atish_choudhury@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. atish_choudhury@dfci.harvard.edu. |
| Source: | NPJ precision oncology [NPJ Precis Oncol] 2026 Apr 28; Vol. 10 (1). Date of Electronic Publication: 2026 Apr 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2397-768X |
|---|---|
| DOI: | 10.1038/s41698-026-01454-6 |
